Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Investigating innate immune dysfunction across inflammatory and fibrotic pulmonary disease


   Institute of Inflammation and Ageing

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Dr Rahul Mahida  Applications accepted all year round  Self-Funded PhD Students Only

About the Project

We are seeking talented, motivated students with a passion for research in acute or chronic pulmonary diseases (e.g. Pneumonia, Acute Respiratory Distress Syndrome, Interstitial Lung Diseases) to join Dr Rahul Mahida’s team in the Institute of Inflammation and Ageing at the University of Birmingham (https://www.birmingham.ac.uk/staff/profiles/inflammation-ageing/mahida-rahul.aspx). Applicants should have a first or upper second-class degree in a relevant scientific discipline, and who are self-funded or have typically applied for, or secured funding for their studies from their government, employer or associated charitable organisations.

Dr Mahida is an Associate Professor in the Birmingham Acute Care Research (BACR) group, a core theme of the Institute of Inflammation and Ageing at the University of Birmingham. His translational research focuses on the role of inflammatory pathways, extracellular vesicles and macrophage dysfunction in the pathogenesis of acute and chronic respiratory diseases. The group’s aim is to develop novel immunomodulatory therapies to promote the resolution of pulmonary inflammation and fibrosis.

Broadly speaking we have three main areas of interest:

• Characterising extracellular vesicle populations and their cargo in patients with acute and chronic pulmonary diseases to identify novel biomarkers.

• Investigating the role of innate immune dysfunction in the pathogenesis of inflammatory pulmonary disease.

• Investigating common pathogenic mechanisms of pulmonary fibrosis across patients with differing aetiologies

We have ongoing projects examining:

• the role of extracellular vesicle-mediated immune dysfunction in patients with Acute Respiratory Distress Syndrome.

• the pro-fibrotic role of extracellular vesicles on leukocytes and fibroblasts in patients with Progressive Pulmonary Fibrosis

• the development of antagomir therapy to target pathogenic microRNAs in pulmonary diseases

• the role of hypoxia-induced immune dysfunction and clinical progression in patients with Interstitial Lung Diseases

• the real-world clinical impact of anti-fibrotic therapies on patients with Progressive Pulmonary Fibrosis

We combine a range of translational research skills, including flow cytometry, fluorescence microscopy, PCR, metabolic profiling, and innate immune functional assays utilising primary human cells and tissue from patients. We incorporate these data with a systems biology approach to large omics datasets (e.g. microRNAseq, metabolomic and proteomic data) and murine models of pulmonary inflammation.

The Institute of Inflammation and Ageing is embedded within the University Hospitals Birmingham NHS Trust, which hosts the largest single-site ICU and one of the largest regional Interstitial Lung Diseases services in the UK. This enables access to large patient cohorts for clinical, translational and data based studies.

PhD projects, using these approaches, answering clinically and/or translationally relevant research questions are available to self-funded or scholarship-funded graduates interested in joining BACR.

Applicants with research experience and/or Master’s degree should apply directly to the Institute of Inflammation and Ageing for a 3 or 4 year full-time PhD – https://www.birmingham.ac.uk/postgraduate/courses/research/med/inflammation-ageing.aspx. This route requires applicants to submit a drafted research proposal.

Applicants seeking additional research experience or who have yet to complete a Master’s degree should apply to the 4 year Integrated Doctoral Training Programme in Life Sciences for Health, which combined a MRes and PhD – https://www.birmingham.ac.uk/postgraduate/pgr/idtp/index.aspx.

Applicants will need to submit the following documentation during the application process.

• Detailed CV, including your nationality and country of birth;

• Covering letter highlighting your research experience/capabilities and why you wish to undertake a PhD in the team;

• Names and addresses of two referees;

• Copies of your degree certificates with transcripts written in English;

• Evidence of your proficiency in the English language, if applicable.

• Evidence of scholarship application/funding or independent funding.

How to apply:

 Applying directly to the Institute of Inflammation and Ageing for either a 3 or 4 year full-time PhD – This route requires applicants to submit a drafted research proposal which should first be agreed with the proposed supervisor (Dr Mahida): https://www.birmingham.ac.uk/postgraduate/courses/research/med/inflammation-ageing.aspx. 

 Applying to the 4 year Integrated Doctoral Training Programme in Life Sciences for Health, which combined a MRes and PhD – https://www.birmingham.ac.uk/postgraduate/pgr/idtp/index.aspx.

Biological Sciences (4) Medicine (26)

Funding Notes

Applicants are invited from self-funded or scholarship-funded graduates ONLY

Applicants will be self-funded or will have typically applied for, or secured funding for their studies from their government, employer or associated charitable organisations.

Overseas graduates require IELTs of 6.5 overall.

References


Google Scholar: https://scholar.google.com/citations?user=MVq3AkgAAAAJ&hl=en

Pubmed page: https://pubmed.ncbi.nlm.nih.gov/?term=mahida+r&sort=date

Selected publications:

Mahida RY, Price J, Lugg ST, Li H, Parekh D, Scott A, Harrison P, Matthay MA, Thickett DR. CD14 positive Extracellular Vesicles in Broncho-Alveolar Lavage Fluid as a New Biomarker of Acute Respiratory Distress Syndrome. Am J Physiol Lung Cell Mol Physiol. 2022 Mar 2. doi:10.1152/ajplung.00052.2022. Online ahead of print. PMID: 35234046

Mahida RY, Scott A, Parekh D, Lugg ST, Belchamber KBR, Hardy RS, Matthay MA, Naidu B, Thickett DR. Assessment of alveolar macrophage dysfunction using an in vitro model of Acute Respiratory Distress Syndrome. Front Med (Lausanne). 2021 Sep 29;8:737859. doi: 10.3389/fmed.2021.737859. PMID: 34660643

Mahida RY, Scott A, Parekh D, Lugg ST, Hardy RS, Lavery GG, Matthay MA, Naidu B, Perkins GD, Thickett DR. Acute Respiratory Distress Syndrome is associated with impaired alveolar macrophage efferocytosis. Eur Respir J. 2021 Sep 9;58(3):2100829. doi: 10.1183/13993003.00829-2021. PMID: 34112730.

Mahida RY, Chotalia M, Alderman J, et al. Characterisation and outcomes of ARDS secondary to pneumonia in patients with and without SARS-CoV-2: a single-centre experience. BMJ Open Respir Res. 2020 Nov;7(1):e000731. PMID: 33257441.

Mahida RY, Matsumoto S, Matthay MA. Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome. Am J Respir Cell Mol Biol. 2020 Jul;63(1):15-24. PMID: 32109144

How good is research at University of Birmingham in Biological Sciences?


Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Where will I study?

Search Suggestions
Search suggestions

Based on your current searches we recommend the following search filters.